437 related articles for article (PubMed ID: 20532540)
41. Altered trafficking of abnormal prion protein in atypical scrapie: prion protein accumulation in oligodendroglial inner mesaxons.
Jeffrey M; González L; Simmons MM; Hunter N; Martin S; McGovern G
Neuropathol Appl Neurobiol; 2017 Apr; 43(3):215-226. PubMed ID: 26750308
[TBL] [Abstract][Full Text] [Related]
42. A brain aggregate model gives new insights into the pathobiology and treatment of prion diseases.
Bajsarowicz K; Ahn M; Ackerman L; Dearmond BN; Carlson G; DeArmond SJ
J Neuropathol Exp Neurol; 2012 May; 71(5):449-66. PubMed ID: 22507918
[TBL] [Abstract][Full Text] [Related]
43. Alteration of cell responses to PrP(Sc) in prolonged cell culture and its effect on transmission of PrP(Sc) to neural cells.
Elhelaly AE; Inoshima Y; Ishiguro N
Arch Virol; 2013 Mar; 158(3):651-8. PubMed ID: 23160705
[TBL] [Abstract][Full Text] [Related]
44. Biochemical fingerprints of prion infection: accumulations of aberrant full-length and N-terminally truncated PrP species are common features in mouse prion disease.
Pan T; Wong P; Chang B; Li C; Li R; Kang SC; Wisniewski T; Sy MS
J Virol; 2005 Jan; 79(2):934-43. PubMed ID: 15613322
[TBL] [Abstract][Full Text] [Related]
45. Pathology of SSLOW, a transmissible and fatal synthetic prion protein disorder, and comparison with naturally occurring classical transmissible spongiform encephalopathies.
Jeffrey M; McGovern G; Makarava N; González L; Kim YS; Rohwer RG; Baskakov IV
Neuropathol Appl Neurobiol; 2014 Apr; 40(3):296-310. PubMed ID: 23578208
[TBL] [Abstract][Full Text] [Related]
46. From high-throughput cell culture screening to mouse model: identification of new inhibitor classes against prion disease.
Geissen M; Leidel F; Eiden M; Hirschberger T; Fast C; Bertsch U; Tavan P; Giese A; Kretzschmar H; Schatzl HM; Groschup MH
ChemMedChem; 2011 Oct; 6(10):1928-37. PubMed ID: 21755599
[TBL] [Abstract][Full Text] [Related]
47. Disease-associated prion protein in neural and lymphoid tissues of mink (Mustela vison) inoculated with transmissible mink encephalopathy.
Schneider DA; Harrington RD; Zhuang D; Yan H; Truscott TC; Dassanayake RP; O'Rourke KI
J Comp Pathol; 2012 Nov; 147(4):508-21. PubMed ID: 22595634
[TBL] [Abstract][Full Text] [Related]
48. Characterization of intracellular dynamics of inoculated PrP-res and newly generated PrP(Sc) during early stage prion infection in Neuro2a cells.
Yamasaki T; Baron GS; Suzuki A; Hasebe R; Horiuchi M
Virology; 2014 Feb; 450-451():324-35. PubMed ID: 24503096
[TBL] [Abstract][Full Text] [Related]
49. Prion protein accumulation in lipid rafts of mouse aging brain.
Agostini F; Dotti CG; Pérez-Cañamás A; Ledesma MD; Benetti F; Legname G
PLoS One; 2013; 8(9):e74244. PubMed ID: 24040215
[TBL] [Abstract][Full Text] [Related]
50. Ultrastructure and pathology of prion protein amyloid accumulation and cellular damage in extraneural tissues of scrapie-infected transgenic mice expressing anchorless prion protein.
Race B; Jeffrey M; McGovern G; Dorward D; Chesebro B
Prion; 2017 Jul; 11(4):234-248. PubMed ID: 28759310
[TBL] [Abstract][Full Text] [Related]
51. Plasma membrane invaginations containing clusters of full-length PrPSc are an early form of prion-associated neuropathology in vivo.
Godsave SF; Wille H; Pierson J; Prusiner SB; Peters PJ
Neurobiol Aging; 2013 Jun; 34(6):1621-31. PubMed ID: 23481568
[TBL] [Abstract][Full Text] [Related]
52. Review: membrane-associated misfolded protein propagation in natural transmissible spongiform encephalopathies (TSEs), synthetic prion diseases and Alzheimer's disease.
Jeffrey M
Neuropathol Appl Neurobiol; 2013 Apr; 39(3):196-216. PubMed ID: 23171056
[TBL] [Abstract][Full Text] [Related]
53. Molecular biology and pathology of prion strains in sporadic human prion diseases.
Gambetti P; Cali I; Notari S; Kong Q; Zou WQ; Surewicz WK
Acta Neuropathol; 2011 Jan; 121(1):79-90. PubMed ID: 21058033
[TBL] [Abstract][Full Text] [Related]
54. Anti-prion Protein Antibody 6D11 Restores Cellular Proteostasis of Prion Protein Through Disrupting Recycling Propagation of PrP
Pankiewicz JE; Sanchez S; Kirshenbaum K; Kascsak RB; Kascsak RJ; Sadowski MJ
Mol Neurobiol; 2019 Mar; 56(3):2073-2091. PubMed ID: 29987703
[TBL] [Abstract][Full Text] [Related]
55. The prion protein and neuronal zinc homeostasis.
Watt NT; Hooper NM
Trends Biochem Sci; 2003 Aug; 28(8):406-10. PubMed ID: 12932728
[TBL] [Abstract][Full Text] [Related]
56. Strain Typing of Prion Diseases Using In Vivo Mouse Models.
Boyle A; Hogan K; Manson JC; Diack AB
Methods Mol Biol; 2017; 1658():263-283. PubMed ID: 28861795
[TBL] [Abstract][Full Text] [Related]
57. Strain-associated variations in abnormal PrP trafficking of sheep scrapie.
Jeffrey M; McGovern G; Goodsir CM; Síso S; González L
Brain Pathol; 2009 Jan; 19(1):1-11. PubMed ID: 18400047
[TBL] [Abstract][Full Text] [Related]
58. Oxidative stress and neurodegeneration in prion diseases.
Kim JI; Choi SI; Kim NH; Jin JK; Choi EK; Carp RI; Kim YS
Ann N Y Acad Sci; 2001 Apr; 928():182-6. PubMed ID: 11795509
[TBL] [Abstract][Full Text] [Related]
59. Prion proteins meet protein quality control.
Dimcheff DE; Portis JL; Caughey B
Trends Cell Biol; 2003 Jul; 13(7):337-40. PubMed ID: 12837603
[TBL] [Abstract][Full Text] [Related]
60. Prion aggregates transfer through tunneling nanotubes in endocytic vesicles.
Zhu S; Victoria GS; Marzo L; Ghosh R; Zurzolo C
Prion; 2015; 9(2):125-35. PubMed ID: 25996400
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
